Clover Health Investments
CLOV
#4652
Rank
โ‚ฌ1.61 B
Marketcap
3,22ย โ‚ฌ
Share price
0.30%
Change (1 day)
250.57%
Change (1 year)

P/E ratio for Clover Health Investments (CLOV)

P/E ratio as of November 2024 (TTM): -6.26

According to Clover Health Investments's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -6.25611. At the end of 2022 the company had a P/E ratio of -1.30.

P/E ratio history for Clover Health Investments from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.30-51.54%
2021-2.68-96.25%
2020-71.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-46.2 638.18%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.